Abstract
One strategy to increase recruitment to trials is to pay healthcare professionals to recruit subjects either by providing financial incentives or by reimbursing excess costs incurred. Many pharmaceutical companies provide inducements but this is not common practice in publicly funded research programmes. Such programmes need to have confidence that payments are worthwhile. We did a systematic review, therefore, to synthesise the evidence on the effectiveness of payment to healthcare professionals for patient recruitment to trials.